Ming Fai International Holdings Limited (3828.HK)
HKD 0.82
(1.23%)
HKD 0.82
(1.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 211.83 Million HKD | 10.9% |
| 2022 | 159.46 Million HKD | 709.95% |
| 2021 | -25.84 Million HKD | -87.34% |
| 2020 | 164.03 Million HKD | -12.03% |
| 2019 | 184.76 Million HKD | 17.43% |
| 2018 | 174.7 Million HKD | -9.77% |
| 2017 | 182.16 Million HKD | -20.64% |
| 2016 | 228.33 Million HKD | 223.63% |
| 2015 | -160.03 Million HKD | -258.48% |
| 2014 | 117.84 Million HKD | -13.79% |
| 2013 | 105.91 Million HKD | -10.55% |
| 2012 | 147.31 Million HKD | 15.91% |
| 2011 | 131.74 Million HKD | -20.91% |
| 2010 | 166.46 Million HKD | 14.47% |
| 2009 | 145.49 Million HKD | -1.89% |
| 2008 | 148.29 Million HKD | -2.12% |
| 2007 | 175.83 Million HKD | 36.38% |
| 2006 | 111.18 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 43.46 Million HKD | 0.0% |
| 2024 Q1 | 43.46 Million HKD | -64.41% |
| 2023 Q3 | 56.75 Million HKD | -29.46% |
| 2023 Q4 | 113.75 Million HKD | 100.45% |
| 2023 Q1 | 41.56 Million HKD | -48.75% |
| 2023 FY | - HKD | 10.9% |
| 2023 Q2 | 80.44 Million HKD | 93.54% |
| 2022 Q2 | 66.29 Million HKD | 82.92% |
| 2022 Q1 | 36.24 Million HKD | 369.34% |
| 2022 Q4 | 81.1 Million HKD | 117.24% |
| 2022 Q3 | 37.33 Million HKD | -43.68% |
| 2022 FY | - HKD | 709.95% |
| 2021 Q2 | -17.05 Million HKD | -76.28% |
| 2021 Q4 | -13.45 Million HKD | -120.14% |
| 2021 Q1 | -9.67 Million HKD | -129.26% |
| 2021 FY | - HKD | -87.34% |
| 2021 Q3 | -6.11 Million HKD | 64.15% |
| 2020 FY | - HKD | -12.03% |
| 2020 Q2 | 82.34 Million HKD | 108.63% |
| 2020 Q4 | 33.05 Million HKD | 0.92% |
| 2020 Q1 | 39.46 Million HKD | -65.01% |
| 2020 Q3 | 32.75 Million HKD | -60.22% |
| 2019 Q4 | 112.8 Million HKD | 111.32% |
| 2019 FY | - HKD | 17.43% |
| 2019 Q3 | 53.38 Million HKD | -32.51% |
| 2019 Q2 | 79.09 Million HKD | 110.91% |
| 2019 Q1 | 37.5 Million HKD | -13.36% |
| 2018 FY | - HKD | -9.77% |
| 2018 Q1 | 36.26 Million HKD | -7.9% |
| 2018 Q2 | 36.26 Million HKD | 0.0% |
| 2018 Q3 | 43.28 Million HKD | 19.36% |
| 2018 Q4 | 43.28 Million HKD | 0.0% |
| 2017 Q2 | 49.81 Million HKD | 0.0% |
| 2017 FY | - HKD | -20.64% |
| 2017 Q1 | 49.81 Million HKD | 17.41% |
| 2017 Q4 | 39.37 Million HKD | 0.0% |
| 2017 Q3 | 39.37 Million HKD | -20.97% |
| 2016 FY | - HKD | 223.63% |
| 2016 Q1 | 37.29 Million HKD | 16.79% |
| 2016 Q3 | 42.43 Million HKD | 13.77% |
| 2016 Q2 | 37.29 Million HKD | 0.0% |
| 2016 Q4 | 42.43 Million HKD | 0.0% |
| 2015 Q3 | 31.93 Million HKD | -18.54% |
| 2015 Q2 | 39.2 Million HKD | 0.0% |
| 2015 Q1 | 39.2 Million HKD | 76.74% |
| 2015 Q4 | 31.93 Million HKD | 0.0% |
| 2015 FY | - HKD | -258.48% |
| 2014 Q1 | 34.54 Million HKD | 30.57% |
| 2014 Q2 | 34.54 Million HKD | 0.0% |
| 2014 Q4 | 22.18 Million HKD | 0.0% |
| 2014 Q3 | 22.18 Million HKD | -35.78% |
| 2014 FY | - HKD | -13.79% |
| 2013 Q3 | 26.45 Million HKD | -34.25% |
| 2013 FY | - HKD | -10.55% |
| 2013 Q4 | 26.45 Million HKD | 0.0% |
| 2013 Q2 | 40.23 Million HKD | 0.0% |
| 2013 Q1 | 40.23 Million HKD | 29.14% |
| 2012 Q1 | 36.84 Million HKD | 0.0% |
| 2012 FY | - HKD | 15.91% |
| 2012 Q4 | 31.15 Million HKD | 0.0% |
| 2012 Q3 | 31.15 Million HKD | -15.44% |
| 2012 Q2 | 36.84 Million HKD | 0.0% |
| 2011 FY | - HKD | -20.91% |
| 2011 Q4 | 36.84 Million HKD | 8.34% |
| 2011 Q3 | 34.01 Million HKD | 0.0% |
| 2011 Q2 | 34.01 Million HKD | 0.0% |
| 2011 Q1 | 34.01 Million HKD | 0.0% |
| 2010 Q2 | 43.26 Million HKD | 0.0% |
| 2010 Q1 | 43.26 Million HKD | 0.0% |
| 2010 FY | - HKD | 14.47% |
| 2010 Q4 | 34.01 Million HKD | -21.39% |
| 2010 Q3 | 43.26 Million HKD | 0.0% |
| 2009 Q4 | 43.26 Million HKD | 17.22% |
| 2009 FY | - HKD | -1.89% |
| 2009 Q1 | 36.91 Million HKD | 0.0% |
| 2009 Q2 | 36.91 Million HKD | 0.0% |
| 2009 Q3 | 36.91 Million HKD | 0.0% |
| 2008 Q1 | 37.11 Million HKD | 0.0% |
| 2008 FY | - HKD | -2.12% |
| 2008 Q3 | 37.11 Million HKD | 0.0% |
| 2008 Q2 | 37.11 Million HKD | 0.0% |
| 2008 Q4 | 36.91 Million HKD | -0.53% |
| 2007 Q3 | 39.01 Million HKD | 0.0% |
| 2007 Q4 | 37.11 Million HKD | -4.87% |
| 2007 FY | - HKD | 36.38% |
| 2007 Q1 | 39.01 Million HKD | 0.0% |
| 2007 Q2 | 39.01 Million HKD | 0.0% |
| 2006 FY | - HKD | 0.0% |
| 2006 Q4 | 39.01 Million HKD | 40.5% |
| 2006 Q1 | 27.76 Million HKD | 0.0% |
| 2006 Q2 | 27.76 Million HKD | 0.0% |
| 2006 Q3 | 27.76 Million HKD | 0.0% |
| 2005 Q4 | 27.76 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -824.555% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 33.332% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -10340.315% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 1176.064% |
| Huasheng International Holding Limited | 19.67 Million HKD | -976.502% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | -244.306% |
| Evergreen Products Group Limited | 140.78 Million HKD | -50.47% |
| EC Healthcare | 737.83 Million HKD | 71.29% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 67.727% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 2963.009% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -720.935% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | -37.388% |